FDA — authorised 22 March 2017
- Application: ANDA207809
- Marketing authorisation holder: ALVOGEN
- Local brand name: MELPHALAN
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Lenalidomide and melphalan in United States
FDA authorised Lenalidomide and melphalan on 22 March 2017
Marketing authorisation
Frequently asked questions
Is Lenalidomide and melphalan approved in United States?
Yes. FDA authorised it on 22 March 2017.
Who is the marketing authorisation holder for Lenalidomide and melphalan in United States?
ALVOGEN holds the US marketing authorisation.